Fort LP’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,434
Closed -$202K 133
2023
Q2
$202K Sell
1,434
-606
-30% -$83.5K 0.53% 130
2023
Q1
$289K Sell
2,040
-898
-31% -$128K 0.75% 62
2022
Q4
$460K Sell
2,938
-893
-23% -$128K 0.7% 20
2022
Q3
$470K Sell
3,831
-2,373
-38% -$313K 0.59% 64
2022
Q2
$825K Sell
6,204
-3,782
-38% -$515K 0.56% 49
2022
Q1
$1.37M Sell
9,986
-723
-7% -$101K 0.52% 70
2021
Q4
$1.85M Sell
10,709
-734
-6% -$112K 0.6% 19
2021
Q3
$1.66M Sell
11,443
-1,490
-12% -$218K 0.55% 34
2021
Q2
$1.71M Sell
12,933
-916
-7% -$120K 0.49% 84
2021
Q1
$1.78M Buy
13,849
+300
+2% +$37K 0.5% 84
2020
Q4
$1.61M Buy
13,549
+2,449
+22% +$299K 0.48% 103
2020
Q3
$1.27M Buy
11,100
+1,487
+15% +$176K 0.53% 44
2020
Q2
$1.09M Sell
9,613
-16,257
-63% -$1.72M 0.59% 26
2020
Q1
$2.08M Sell
25,870
-464
-2% -$48K 0.47% 102
2019
Q4
$2.81M Sell
26,334
-1,225
-4% -$128K 0.5% 70
2019
Q3
$2.95M Buy
27,559
+3,014
+12% +$309K 0.55% 33
2019
Q2
$2.5M Buy
24,545
+2,623
+12% +$252K 0.48% 92
2019
Q1
$1.97M Buy
21,922
+5,617
+34% +$487K 0.4% 134
2018
Q4
$1.36M Buy
16,305
+7,037
+76% +$660K 0.32% 142
2018
Q3
$1M Buy
9,268
+8,163
+739% +$895K 0.22% 74
2018
Q2
$121K Buy
+1,105
New +$115K 0.03% 94
2015
Q2
Sell
-19,364
Closed -$1.49M 49
2015
Q1
$1.49M Sell
19,364
-17,157
-47% -$1.23M 0.76% 31
2014
Q4
$2.45M Buy
+36,521
New +$2.3M 1.94% 21

Other funds holding DGX

Fort LP's DGX Position: Q3 2023 in Review

Fort LP sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 1,434 shares — an estimated $202K sold.

Fort LP first reported a position in DGX in Q4 2014 and held it in 23 quarters. The position peaked at $2.95M in Q3 2019. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Fort LP reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Fort LP sold 1,434 Quest Diagnostics shares in Q3 2023, an estimated $202K.
  • Fort LP first reported a position in Quest Diagnostics in Q4 2014 and held it in 23 quarters.
  • Fort LP's Quest Diagnostics position peaked at $2.95M in Q3 2019.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Fort LP's 13F filing for Q3 2023, filed 13 Nov 2023.